Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thrombolysis plus tirofiban versus thrombolysis alone in acute ischemic stroke
ChiCTR2100052029Phase 3Not yet recruiting
- Sponsor
- First Affiliated Hospital of Bengbu Medical University
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of tirofiban in ischemic stroke (2 arms), sponsored by First Affiliated Hospital of Bengbu Medical University. Primary endpoint: Modified Rankin Scale score (%) at 90 days. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2100052029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052029.